Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study

BACKGROUND: Most guidelines recommend rapid treatment initiation for patients with newly diagnosed human immunodeficiency virus type 1 (HIV-1) infection, but prospective US data are limited. The DIAMOND (NCT03227861) study using darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 80...

Descripción completa

Detalles Bibliográficos
Autores principales: Huhn, Gregory D, Crofoot, Gordon, Ramgopal, Moti, Gathe, Joseph, Bolan, Robert, Luo, Donghan, Simonson, Richard Bruce, Nettles, Richard E, Benson, Carmela, Dunn, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819515/
https://www.ncbi.nlm.nih.gov/pubmed/31879782
http://dx.doi.org/10.1093/cid/ciz1213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819515/
https://www.ncbi.nlm.nih.gov/pubmed/31879782
http://dx.doi.org/10.1093/cid/ciz1213

Ejemplares similares